AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcus Biosciences, Inc. Director's Dealing 2024

Jun 18, 2024

31966_dirs_2024-06-18_9a937717-c27c-460a-9430-41e4dd921093.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2024-06-15

Reporting Person: Jaen Juan C. (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-15	Common Stock	F	6969	$16.97	Disposed	334506	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1188233	Indirect

Footnotes

F1: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.